| 000 | 01530 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517094024.0 | ||
| 264 | 0 | _c20171225 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1878-5905 | ||
| 024 | 7 |
_a10.1016/j.biomaterials.2016.03.039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSiefert, Alyssa L | |
| 245 | 0 | 0 |
_aArtificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy. _h[electronic resource] |
| 260 |
_bBiomaterials _c08 2016 |
||
| 300 |
_a85-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
| 650 | 0 | 4 |
_aBacterial Vaccines _ximmunology |
| 650 | 0 | 4 |
_aBiomimetic Materials _xpharmacology |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 |
_aLipid A _xanalogs & derivatives |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aPathogen-Associated Molecular Pattern Molecules _xmetabolism |
| 650 | 0 | 4 |
_aTh1 Cells _xdrug effects |
| 650 | 0 | 4 |
_aToll-Like Receptors _xmetabolism |
| 700 | 1 | _aCaplan, Michael J | |
| 700 | 1 | _aFahmy, Tarek M | |
| 773 | 0 |
_tBiomaterials _gvol. 97 _gp. 85-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biomaterials.2016.03.039 _zAvailable from publisher's website |
| 999 |
_c26003944 _d26003944 |
||